Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUSOT: Oseltamivir effectiveness and influenza vaccine effectiveness in solid organ transplant recipients
NL-OMON21725Not yet recruiting
- Start
- Mar 2020
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of oseltamivir and influenza vaccine in influenza and Respiratory viral illness (4 arms), sponsored by none. Primary endpoint: 30-day mortality. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
oseltamivirinfluenza vaccine
03
Conditions
influenzaRespiratory viral illness
Beyond the preview
Go deeper on NL-OMON21725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21725.